TY - JOUR
TI - Comparison of MIC test strip and sensititre YeastOne with the CLSI and EUCAST broth microdilution reference methods for in vitro antifungal susceptibility testing of Cryptococcus neoformans
AU - Delma, F.Z.
AU - Al-Hatmi, A.M.S.
AU - Buil, J.B.
AU - Van Der Lee, H.
AU - Tehupeiory-Kooreman, M.
AU - Sybren De Hoog, G.
AU - Meletiadis, J.
AU - Verweij, P.E.
JO - Antimicrobial Agents and Chemotherapy
PY - 2020
VL - 64
TODO - 4
SP - null
PB - American Society for Microbiology
SN - 0066-4804, 1098-6596
TODO - 10.1128/AAC.02261-19
TODO - amphotericin B;  fluconazole;  flucytosine;  isavuconazole;  voriconazole;  antifungal agent, antifungal susceptibility;  Article;  broth dilution;  Cryptococcus neoformans;  device comparison;  fungus isolation;  in vitro study;  minimum inhibitory concentration;  nonhuman;  priority journal;  comparative study;  cryptococcosis;  Cryptococcus neoformans;  drug effect;  human;  isolation and purification;  microbial sensitivity test;  microbiology;  procedures;  time factor, Antifungal Agents;  Cryptococcosis;  Cryptococcus neoformans;  Humans;  Microbial Sensitivity Tests;  Time Factors
TODO - We compared MIC test strip (MTS) and Sensititre YeastOne (SYO) methods with EUCAST and CLSI methods for amphotericin B, 5-fluocytosine, fluconazole, voriconazole, and isavuconazole against 106 Cryptococcus neoformans isolates. The overall essential agreement between the EUCAST and CLSI methods was >72% and >94% at ±1 and ±2 dilutions, respectively. The essential agreements between SYO and EUCAST/CLSI for amphotericin B, 5-flucytosine, fluconazole, and voriconazole were >89/>93% and between MTS and EUCAST/CLSI were >57/>75%. Very major error rates were low for amphotericin B and fluconazole (<3%) and a bit higher for the other drugs (<8%). Copyright © 2020 American Society for Microbiology. All Rights Reserved.
ER -